N-[4-(2-Oxo-2,3-Dihydro-1h-Benzimidazol-1- Yl)Piperidin-1-Ylcarbonyl]-[3(S)-Methyl]-D- Tryptophyl-L-Lysine Tert-Butyl Ester manufacturers
- L-054,522
-
- $3028.00
-
2026-05-11
- CAS:214348-67-1
- Purity:
- Supply Ability: 10g
|
| | N-[4-(2-Oxo-2,3-Dihydro-1h-Benzimidazol-1- Yl)Piperidin-1-Ylcarbonyl]-[3(S)-Methyl]-D- Tryptophyl-L-Lysine Tert-Butyl Ester Basic information |
| | N-[4-(2-Oxo-2,3-Dihydro-1h-Benzimidazol-1- Yl)Piperidin-1-Ylcarbonyl]-[3(S)-Methyl]-D- Tryptophyl-L-Lysine Tert-Butyl Ester Chemical Properties |
| density | 1.252±0.06 g/cm3(Predicted) | | pka | 12.02±0.30(Predicted) |
| | N-[4-(2-Oxo-2,3-Dihydro-1h-Benzimidazol-1- Yl)Piperidin-1-Ylcarbonyl]-[3(S)-Methyl]-D- Tryptophyl-L-Lysine Tert-Butyl Ester Usage And Synthesis |
| Uses | L-054522 is an agonist for somatostatin receptor subtype 2 with Kd of 0.01 nM. L-054522 inhibits growth hormone release from rat primary pituitary cell (IC50=0.05 nM) and glucagon and insulin release from isolated mouse pancreatic islet cell (IC50=0.05 nM and 12 nM)[1]. | | References | [1] Yang L, et al., Synthesis and biological activities of potent peptidomimetics selective for somatostatin receptor subtype 2. Proc Natl Acad Sci U S A. 1998 Sep 1;95(18):10836-41. DOI:10.1073/pnas.95.18.10836 |
| | N-[4-(2-Oxo-2,3-Dihydro-1h-Benzimidazol-1- Yl)Piperidin-1-Ylcarbonyl]-[3(S)-Methyl]-D- Tryptophyl-L-Lysine Tert-Butyl Ester Preparation Products And Raw materials |
|